MedTrace Logo

Implementation of Physiotherapy on COVID-19 Patients in ICU

NCT04347070 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2020-12-29

No results posted yet for this study

Summary

Despite new charachersitics of COVID-19 patients, critical care implementation seems to be similar to those with Acute Respiratory Distress Syndrome (ARDS) in intensive care units (ICU).

Regarding the initial gravity of these patients, sedation and neuromuscular blockers are usually administrated, increasing the risk to develope an ICU-acquired weakness which is directly correlated to morbi-mortality and a burden during recovery.

Respiratory symptoms are mostly related to dyspnoea and non-productive cough, with only 33% of COVID-19 patient having a bronchial hypersecretion ; consequently, chest physiotherapy is only implemented in after case-by-case evaluation.

This unprecedented situation requires to identify how physiotherapy is being implemented in COVID-19 patients in ICU.

This retrospective, multicentric study aims to identify the charactheristics of physiotherapy (type and time spent) implemented in Argentina, Belgium, Chili, France, Italy and Spain

Conditions

Interventions

OTHER

Phsyiotherapy

To observe if patients with COVID-19 benefice of physiothersapy, which kind and how many time

Sponsors & Collaborators

  • Société espagnole de pneumologie (SEPAR)

    collaborator UNKNOWN

  • Societe française de kinésithérapie en réanimation (SKR)

    collaborator UNKNOWN

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • Roberto Martinez-Alejos, MD, PhD · University Hospital, Montpellier

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-01
Primary Completion
2020-09-01
Completion
2022-12-01

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04347070 on ClinicalTrials.gov